Patient-reported outcomes in a Chinese cohort of osteogenesis imperfecta unveil psycho-physical stratifications associated with clinical manifestations.
Adults
Children
Cross-sectional
Genetic testing
Longitudinal
Osteogenesis imperfecta
PROM
Patient stratification
Psycho-physical
Rare disease
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
28 06 2022
28 06 2022
Historique:
received:
17
06
2021
accepted:
11
06
2022
entrez:
28
6
2022
pubmed:
29
6
2022
medline:
1
7
2022
Statut:
epublish
Résumé
Osteogenesis imperfecta (OI) is a rare congenital disorder of the skeletal system, inflicting debilitating physical and psychological distress on patients and caregivers. Over the decades, much effort has been channeled towards understanding molecular mechanisms and developing new treatments. It has recently become more apparent that patient-reported outcome measurements (PROM) during treatment, healing and rehabilitation are helpful in facilitating smoother communication, refining intervention strategies and achieving higher quality of life. To date, systematic analyses of PROM in OI patients remain scarce. Here, utilizing a PROM Information System, we report a cross-sectional and longitudinal study in a southern Chinese cohort of 90 OI patients, covering both the child and adult age-groups. In the child group where both self and parental surveys were obtained, we identified two clusters of comparable sizes showing different outlooks in physical mobility and emotional experiences. One cluster (Cluster 1) is more negative about themselves than the other (Cluster 2). A concordance of 84.7% between self and parental assessments was recorded, suggesting the stability and validity of PROM-based stratification. Clinical subtyping, deformity, leg length discrepancy, and limited joint mobility were significantly associated with this stratification, with Cluster 1 showing higher percentages of severe phenotypes than Cluster 2. Since OI is a genetic disorder, we performed genetic testing on 72 of the 90 patients, but found no obvious association between genotypes and the PROM stratification. Analyses of longitudinal data suggested that patients tended to stay in the same psychological state, in both clusters. Adult patients also showed a continuous spectrum of self-evaluation that matches their clinical manifestations. By systematically analyzing patient-reported outcomes, our study demonstrated the link between the sociopsychological wellbeing of OI patients, and their clinical manifestations, which may serve as the basis for evaluating clinical interventions and help achieve better patient-centric medical practices. The lack of genotype-PROM association may be due to the diverse mutational spectrum in OI, which warrants further investigation when a larger sample size is available.
Sections du résumé
BACKGROUND
Osteogenesis imperfecta (OI) is a rare congenital disorder of the skeletal system, inflicting debilitating physical and psychological distress on patients and caregivers. Over the decades, much effort has been channeled towards understanding molecular mechanisms and developing new treatments. It has recently become more apparent that patient-reported outcome measurements (PROM) during treatment, healing and rehabilitation are helpful in facilitating smoother communication, refining intervention strategies and achieving higher quality of life. To date, systematic analyses of PROM in OI patients remain scarce.
RESULTS
Here, utilizing a PROM Information System, we report a cross-sectional and longitudinal study in a southern Chinese cohort of 90 OI patients, covering both the child and adult age-groups. In the child group where both self and parental surveys were obtained, we identified two clusters of comparable sizes showing different outlooks in physical mobility and emotional experiences. One cluster (Cluster 1) is more negative about themselves than the other (Cluster 2). A concordance of 84.7% between self and parental assessments was recorded, suggesting the stability and validity of PROM-based stratification. Clinical subtyping, deformity, leg length discrepancy, and limited joint mobility were significantly associated with this stratification, with Cluster 1 showing higher percentages of severe phenotypes than Cluster 2. Since OI is a genetic disorder, we performed genetic testing on 72 of the 90 patients, but found no obvious association between genotypes and the PROM stratification. Analyses of longitudinal data suggested that patients tended to stay in the same psychological state, in both clusters. Adult patients also showed a continuous spectrum of self-evaluation that matches their clinical manifestations.
CONCLUSION
By systematically analyzing patient-reported outcomes, our study demonstrated the link between the sociopsychological wellbeing of OI patients, and their clinical manifestations, which may serve as the basis for evaluating clinical interventions and help achieve better patient-centric medical practices. The lack of genotype-PROM association may be due to the diverse mutational spectrum in OI, which warrants further investigation when a larger sample size is available.
Identifiants
pubmed: 35765008
doi: 10.1186/s13023-022-02394-7
pii: 10.1186/s13023-022-02394-7
pmc: PMC9238011
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
249Informations de copyright
© 2022. The Author(s).
Références
Orphanet J Rare Dis. 2015 Nov 14;10:146
pubmed: 26578084
Bioinformatics. 2014 Oct 15;30(20):2843-51
pubmed: 24974202
J Med Genet. 1979 Apr;16(2):101-16
pubmed: 458828
J Bone Miner Res. 2020 Aug;35(8):1470-1480
pubmed: 32181939
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
J Clin Epidemiol. 2010 Nov;63(11):1179-94
pubmed: 20685078
Arch Phys Med Rehabil. 1999 Aug;80(8):896-903
pubmed: 10453765
Osteoporos Int. 2017 Oct;28(10):2985-2995
pubmed: 28725987
Front Pharmacol. 2019 Oct 15;10:1200
pubmed: 31680973
Orphanet J Rare Dis. 2021 Mar 20;16(1):140
pubmed: 33743784
Birth Defects Orig Artic Ser. 1979;15(5B):113-29
pubmed: 393318
J Pediatr Health Care. 2019 Jul - Aug;33(4):437-445
pubmed: 30827754
Hum Genomics. 2017 Aug 15;11(1):19
pubmed: 28810924
Paediatr Anaesth. 2022 Jul;32(7):851-861
pubmed: 35384138
BMC Pediatr. 2013 Sep 30;13:153
pubmed: 24074180
Am J Med Genet A. 2014 Jun;164A(6):1470-81
pubmed: 24715559
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
J Bone Miner Res. 2010 Jun;25(6):1367-74
pubmed: 19929435
Health Qual Life Outcomes. 2015 Apr 01;13:41
pubmed: 25889100
Am J Hum Genet. 2019 Oct 3;105(4):836-843
pubmed: 31564437
J Med Genet. 2018 Apr;55(4):278-284
pubmed: 29358272
Calcif Tissue Int. 2017 Nov;101(5):473-478
pubmed: 28676897
Bioinformatics. 2019 Feb 15;35(4):628-635
pubmed: 30101339
Front Genet. 2022 Jan 28;13:816078
pubmed: 35154279
Am J Med Genet A. 2016 Jan;170A(1):62-76
pubmed: 26365089
Adv Clin Exp Med. 2012 Jan-Feb;21(1):99-104
pubmed: 23214306
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
Eur J Hum Genet. 2015 Aug;23(8):1042-50
pubmed: 25944380
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Orphanet J Rare Dis. 2016 Nov 28;11(1):160
pubmed: 27894323
Hum Mutat. 2007 Mar;28(3):209-21
pubmed: 17078022
Ann Hum Genet. 2021 Jan;85(1):37-46
pubmed: 32770541
Front Genet. 2020 Sep 15;11:984
pubmed: 33093841
Orphanet J Rare Dis. 2019 Jan 29;14(1):23
pubmed: 30696467
Lancet. 2016 Apr 16;387(10028):1657-71
pubmed: 26542481
Nat Rev Dis Primers. 2017 Aug 18;3:17052
pubmed: 28820180
JBMR Plus. 2020 Nov 07;4(12):e10416
pubmed: 33354642
J Osteoporos. 2011;2011:540178
pubmed: 21912751